Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
alder biopharmaceuticals
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
the medicines company
wisconsin blog main
wisconsin top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alexion pharmaceuticals
alirocumab
What
drug
new
3
×
brings
fda
medicines
acquire
advantages
agreed
amgen
approval
bar
billion
bio
candidates
cash
cholesterol
class
company
compound
deal
developed
expect
gamble
gets
head
market
medco
medco’s
migraine
mover
nod
novartis
pain
patients
payers
physicians
plan
poised
preventive
pricing
Language
unset
Current search:
novartis
×
amgen
×
new
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines